Haemonetics Operating Income 2010-2025 | HAE

Haemonetics operating income from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Haemonetics Annual Operating Income
(Millions of US $)
2025 $222
2024 $165
2023 $156
2022 $81
2021 $90
2020 $103
2019 $84
2018 $56
2017 $-19
2016 $-44
2015 $41
2014 $46
2013 $56
2012 $89
2011 $111
2010 $83
2009 $86
Haemonetics Quarterly Operating Income
(Millions of US $)
2025-03-31 $71
2024-12-31 $59
2024-09-30 $52
2024-06-30 $40
2024-03-31 $30
2023-12-31 $46
2023-09-30 $35
2023-06-30 $54
2023-03-31 $35
2022-12-31 $43
2022-09-30 $47
2022-06-30 $31
2022-03-31 $19
2021-12-31 $36
2021-09-30 $25
2021-06-30 $1
2021-03-31 $-21
2020-12-31 $40
2020-09-30 $59
2020-06-30 $12
2020-03-31 $26
2019-12-31 $41
2019-09-30 $50
2019-06-30 $-13
2019-03-31 $24
2018-12-31 $28
2018-09-30 $26
2018-06-30 $5
2018-03-31 $14
2017-12-31 $1
2017-09-30 $24
2017-06-30 $17
2017-03-31 $-58
2016-12-31 $21
2016-09-30 $25
2016-06-30 $-8
2016-03-31 $-6
2015-12-31 $-61
2015-09-30 $19
2015-06-30 $4
2015-03-31 $12
2014-12-31 $18
2014-09-30 $12
2014-06-30 $-2
2014-03-31 $12
2013-12-31 $18
2013-09-30 $23
2013-06-30 $-7
2013-03-31 $18
2012-12-31 $16
2012-09-30 $10
2012-06-30 $13
2012-03-31 $21
2011-12-31 $25
2011-09-30 $19
2011-06-30 $24
2011-03-31 $29
2010-12-31 $29
2010-09-30 $29
2010-06-30 $24
2010-03-31 $4
2009-12-31 $26
2009-09-30 $27
2009-06-30 $26
2009-03-31 $18
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.521B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $225.007B 26.38
Boston Scientific (BSX) United States $154.324B 36.80
Stryker (SYK) United States $144.711B 29.46
EssilorLuxottica (ESLOY) France $142.399B 0.00
Medtronic (MDT) Ireland $117.900B 16.72
Lonza Group Ag (LZAGY) Switzerland $48.114B 0.00
Haleon (HLN) United Kingdom $43.571B 24.87
ResMed (RMD) United States $41.687B 29.81
Agilent Technologies (A) United States $33.767B 22.01
GE HealthCare Technologies (GEHC) United States $33.630B 15.81
Terumo (TRUMY) Japan $27.538B 32.63
Koninklijke Philips (PHG) Netherlands $26.220B 17.34
Insulet (PODD) United States $22.229B 74.48
Zimmer Biomet Holdings (ZBH) United States $20.230B 12.88
Smith & Nephew SNATS (SNN) United Kingdom $16.039B 0.00
Baxter (BAX) United States $12.558B 9.70
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.773B 28.55
Lantheus Holdings (LNTH) United States $3.704B 10.01
Envista Holdings (NVST) United States $3.460B 24.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.179B 14.10
Perrigo (PRGO) Ireland $3.169B 7.91
ICU Medical (ICUI) United States $2.762B 18.81
LeMaitre Vascular (LMAT) United States $2.169B 46.51
Curaleaf Holdings (CURLF) Canada $1.969B 0.00
Green Thumb Industries (GTBIF) United States $1.827B 78.46
QuidelOrtho (QDEL) United States $1.762B 11.09
AtriCure (ATRC) United States $1.760B 0.00
Tilray Brands (TLRY) Canada $1.299B 0.00
AdaptHealth (AHCO) United States $1.284B 18.25
Phibro Animal Health (PAHC) United States $1.239B 15.84
BioLife Solutions (BLFS) United States $1.213B 2532.00
Neogen (NEOG) United States $1.195B 18.97
Acuren (TIC) United States $1.153B 0.00
InMode (INMD) Israel $0.903B 8.35
Valneva SE (VALN) France $0.891B 0.00
Kestra Medical Technologies (KMTS) United States $0.820B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.662B 0.00
SNDL (SNDL) Canada $0.554B 0.00
Verano Holdings (VRNOF) United States $0.543B 0.00
Surmodics (SRDX) United States $0.538B 0.00
ZimVie (ZIMV) United States $0.531B 20.47
Cresco Labs (CRLBF) United States $0.489B 0.00
VAREX IMAGING (VREX) United States $0.447B 15.40
CeriBell (CBLL) United States $0.432B 0.00
Owens & Minor (OMI) United States $0.417B 3.70
Evolus (EOLS) United States $0.414B 0.00
Canopy Growth (CGC) Canada $0.357B 0.00
Capricor Therapeutics (CAPR) United States $0.356B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.330B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
Aurora Cannabis (ACB) Canada $0.304B 0.00
Sanara MedTech (SMTI) United States $0.271B 0.00
Viemed Healthcare (VMD) United States $0.267B 20.26
Omeros (OMER) United States $0.254B 0.00
TerrAscend (TSNDF) Canada $0.251B 0.00
Cerus (CERS) United States $0.243B 0.00
Brainsway (BWAY) Israel $0.242B 49.35
Vireo Growth (VREOF) United States $0.240B 0.00
Quanterix (QTRX) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.209B 0.00
High Tide (HITI) Canada $0.207B 0.00
Exagen (XGN) United States $0.206B 0.00
OraSure Technologies (OSUR) United States $0.203B 0.00
Utah Medical Products (UTMD) United States $0.182B 15.21
FitLife Brands (FTLF) United States $0.152B 18.67
Biote (BTMD) United States $0.147B 4.89
TriSalus Life Sciences (TLSI) United States $0.147B 0.00
Jushi Holdings (JUSHF) United States $0.130B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.099B 0.00
Fonar (FONR) United States $0.094B 12.14
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.080B 0.00
Safety Shot (SHOT) United States $0.074B 0.00
Cytosorbents (CTSO) United States $0.072B 0.00
ImmuCell (ICCC) United States $0.061B 35.37
Agape ATP (ATPC) $0.061B 0.00
Veru (VERU) United States $0.054B 0.00
MariMed (MRMD) United States $0.051B 0.00
Zynex (ZYXI) United States $0.048B 0.00
Nephros (NEPH) United States $0.042B 33.33
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.036B 14.04
Rockwell Medical (RMTI) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00